Literature DB >> 14761100

Risks of untreated depression during pregnancy.

Lori Bonari1, Heather Bennett, Adrienne Einarson, Gideon Koren.   

Abstract

QUESTION: One of my patients who was taking an antidepressant for major depression is now pregnant and does not wish to take it any more. I believe she needs to continue her medication. She, however, is adamant about stopping it because she believes it would put her baby at risk. Is there evidence that not treating depression during pregnancy puts babies at risk? ANSWER: A growing body of literature investigating the effects of not treating depression on mother and developing fetus suggests that untreated depression is associated with adverse fetal outcomes and a higher risk of maternal morbidity, including suicide ideation and attempts, and postpartum depression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14761100      PMCID: PMC2214485     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  20 in total

1.  Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies.

Authors:  A Addis; G Koren
Journal:  Psychol Med       Date:  2000-01       Impact factor: 7.723

2.  Risk-benefit decision making for treatment of depression during pregnancy.

Authors:  K L Wisner; D A Zarin; E S Holmboe; P S Appelbaum; A J Gelenberg; H L Leonard; E Frank
Journal:  Am J Psychiatry       Date:  2000-12       Impact factor: 18.112

Review 3.  Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings.

Authors:  S T Orr; C A Miller
Journal:  Epidemiol Rev       Date:  1995       Impact factor: 6.222

4.  Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling.

Authors:  A Einarson; P Selby; G Koren
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

5.  Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications.

Authors:  A Hostetter; Z N Stowe; J R Strader; E McLaughlin; A Llewellyn
Journal:  Depress Anxiety       Date:  2000       Impact factor: 6.505

6.  Depression and anxiety in early pregnancy and risk for preeclampsia.

Authors:  T Kurki; V Hiilesmaa; R Raitasalo; H Mattila; O Ylikorkala
Journal:  Obstet Gynecol       Date:  2000-04       Impact factor: 7.661

7.  Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women.

Authors:  S Hoffman; M C Hatch
Journal:  Health Psychol       Date:  2000-11       Impact factor: 4.267

8.  Depressive symptoms during pregnancy: relationship to poor health behaviors.

Authors:  B Zuckerman; H Amaro; H Bauchner; H Cabral
Journal:  Am J Obstet Gynecol       Date:  1989-05       Impact factor: 8.661

9.  Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study.

Authors:  J M Teixeira; N M Fisk; V Glover
Journal:  BMJ       Date:  1999-01-16

10.  Self-reported depression and negative pregnancy outcomes.

Authors:  R A Steer; T O Scholl; M L Hediger; R L Fischer
Journal:  J Clin Epidemiol       Date:  1992-10       Impact factor: 6.437

View more
  16 in total

Review 1.  Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?

Authors:  Gideon Koren; Doreen Matsui; Adrienne Einarson; David Knoppert; Meir Steiner
Journal:  CMAJ       Date:  2005-05-24       Impact factor: 8.262

2.  Prevention of supine hypotensive syndrome in pregnant women treated with transcranial magnetic stimulation.

Authors:  Deborah Rubin Kim; Eileen Wang
Journal:  Psychiatry Res       Date:  2014-04-12       Impact factor: 3.222

3.  Psychotropic Drug Use before, during, and after Pregnancy: A Population-Based Study in a Canadian Cohort (2001-2013).

Authors:  Christine Leong; Colette Raymond; Dan Château; Matthew Dahl; Silvia Alessi-Severini; Jamie Falk; Shawn Bugden; Alan Katz
Journal:  Can J Psychiatry       Date:  2017-05-25       Impact factor: 4.356

4.  Prenatal depression in Latinas in the U.S. and Mexico.

Authors:  Ma Asunción Lara; Huynh-Nhu Le; Gabriela Letechipia; Laila Hochhausen
Journal:  Matern Child Health J       Date:  2008-06-26

Review 5.  Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?

Authors:  Claudio N Soares; Brook Zitek
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

6.  Postpartum anxiety and comorbid depression in a population-based sample of women.

Authors:  Sherry L Farr; Patricia M Dietz; Michael W O'Hara; Kim Burley; Jean Y Ko
Journal:  J Womens Health (Larchmt)       Date:  2013-10-26       Impact factor: 2.681

Review 7.  Depression screening and treatment among nonpregnant women of reproductive age in the United States, 1990-2010.

Authors:  Sherry L Farr; Patricia M Dietz; Jessica R Williams; Falicia A Gibbs; Stephen Tregear
Journal:  Prev Chronic Dis       Date:  2011-10-17       Impact factor: 2.830

Review 8.  Preconception care: screening and management of chronic disease and promoting psychological health.

Authors:  Zohra S Lassi; Ayesha M Imam; Sohni V Dean; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

9.  The effect of antenatal depression on birth weight among newborns in South Gondar zone, Northwest Ethiopia: a population-based prospective cohort study.

Authors:  Getnet Mihretie Beyene; Telake Azale; Kassahun Alemu Gelaye; Tadesse Awoke Ayele
Journal:  Arch Public Health       Date:  2021-07-05

10.  Mamma mia: a feasibility study of a web-based intervention to reduce the risk of postpartum depression and enhance subjective well-being.

Authors:  Silje Marie Haga; Filip Drozd; Håvar Brendryen; Kari Slinning
Journal:  JMIR Res Protoc       Date:  2013-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.